Testosterone Is Sure Looking Virile Oct 31, 2009
6 billion to acquire Solvay Pharmaceuticals, which makes the leading testosterone product, AndroGel ... The FDA, having received more than 20 reports of testosterone in commercial products rubbing off on children, required that dreaded "black box" warnings be added to the labels for AndroGel and Auxilium's rival product, Testim ... Auxilium CEO Armando Anido admits he doesn't have the capital to invest in heavy advertising, as Solvay has done with AndroGel. (BusinessWeek)
FTC, drugstores sue Solvay over delay in generic AndroGel Oct 25, 2009
The and several national pharmacy chains are suing Marietta-based for allegedly colluding to block the generic release of AndroGel, a top-selling product ... AndroGel, marketed as a treatment for men with low testosterone levels, rang up more than $400 million in global sales last year ... The AndroGel suits allege Solvay conspired with the generic defendants to monopolize the market. (Atlanta Business Chronicle, GA)
Abbott buys Solvay pharma operations for $6.6B Sep 30, 2009
Solvay's other top-selling drugs include the Parkinson's disease treatment Duodopa and hormone therapy drugs AndroGel and Duphaston. Monday's announcement is the latest in a string of mergers and acquisitions, as cash-rich pharmaceutical companies race to acquire new products amid looming patent expirations. (Yahoo News -- Pharmaceutical Industry News)
AstraZeneca May Pay Top Dollar for Drugs to Combat Onslaught of Generics Jun 4, 2009
He estimates the division, which also sells flu vaccines and the male-hormone therapy Androgel, is valued at 5. 5 billion to 7 billion euros ($7. (Bloomberg -- UK)
Newsweek: Do men need testosterone supplements? May 21, 2009
Competing with your Playboy subscription, however, are prescription drugs-including the futuristic sounding AndroGel, a testosterone foam that hormone-challenged men have been rubbing on their bodies for almost a decade ... The result is a potentially huge drug market-especially if AndroGel can encourage men to believe that "lost height," "falling asleep after dinner" and a "deterioration of your ability to play sports" are symptoms that can be fixed the same way Viagra fixes erectile... (MSNBC -- Health)
FDA: Kids At Risk From Testosterone Gel May 9, 2009
8 million prescriptions in 2007 for testosterone gel, with the leading brand, AndroGel, accounting for about three-fourths of the sales. "These drugs are approved for an important medical need, but can have serious unintended side effects if not used properly," Dr. Janet Woodcock, director of the FDA's drug division, said in a statement. (KIRO TV, WA)
FDA Orders Label Warning for Testosterone Gels May 9, 2009
The two affected prescription medications are AndroGel 1%, made by Solvay Pharmaceuticals, and Testim 1%, made by Auxilium Pharmaceuticals ... 4 million prescriptions for the most popular medication, AndroGel, and about 370,000 prescriptions for Testim ... And they added that women should not use either gel, despite the fact the agency found that about 25,000 of the AndroGel prescriptions in 2007 were, in fact, dispensed to women. (MEDLINEplus)
FDA warns of testosterone gel effects in kids May 8, 2009
AndroGel and Testim approved for use in men who produce little or no testosterone ... The gels, AndroGel and Testim, are approved for use in men who produce little or no testosterone ... 4 million prescriptions dispensed for AndroGel -- 25,000 of which were for women -- and 370,000 for Testim. (CNN -- Health)
Custom-made meds maypose threat Mar 12, 2009
In this case, the standard prescription testosterone gel (Androgel) is suitable only for men, delivering several times the daily dose Sticka's doctor prescribed. advertisement. (MSNBC -- Health)
Lawmakers propose bill to stop generic drug delays Feb 9, 2009
It filed suit last week against Solvay SA, which had struck deals in 2006 with generic drug companies Watson Pharmaceuticals Inc, Par Pharmaceuticals and Paddock Laboratories to delay their production of a cheaper version of Solvay's testosterone-replacement therapy AndroGel. But U.S. courts are divided on the issue. (Yahoo News -- Pharmaceutical Industry News)
FTC accuses firms of delaying generic drug launch Feb 9, 2009
Androgel, a gel-based testosterone drug, is Solvay's best-selling product with U.S. sales over $300 million. Instead of competing against Solvay, the FTC states that the generic companies agreed to help market and manufacture Androgel ... "These agreements deny consumers the opportunity to purchase lower-cost generic versions of AndroGel, at a cost of hundreds of millions of dollars a year," the FTC states in its complaint, filed in a U.S. District Court in California. (Yahoo News -- Pharmaceutical Industry News)
FTC critical of delay in generic drugs Feb 8, 2009
Androgel, a gel-based testosterone drug, is Solvay's best- selling product with U.S. sales over 300 million. Instead of competing against Solvay, the FTC states that the generic companies agreed to help market and manufacture Androgel ... "These agreements deny consumers the opportunity to purchase lower-cost generic versions of AndroGel, at a cost of hundreds of millions of dollars a year," the FTC states in its complaint, filed in a U.S. District Court in California. (Montana Standard, MT)
Consumers are more important than stuffing drug-company coffers Feb 8, 2009
Solvay Pharmaceuticals is understandably pleased with AndroGel, the synthetic testosterone gel it developed in 2003 ... In applications to the Food and Drug Administration, Watson Pharmaceuticals, Par Pharmaceuticals, and Paddock Laboratories argued that Solvay's patent wasn't valid and that, in any case, they could manufacture generic versions of AndroGel without infringing upon it. (Daily Iowan, IA)
